ARNA is up around 50% on its report that ralinepag was successful in mid-stage PAH study.Phase 2 results are driving the stock up today: $ARNA, Arena Pharmaceuticals, Inc. / H1 ARNA stock is a dead cat bounce. Agree = Avoid.Disagree = ARNA stock has legs to move to the $1 billion market cap.